Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Biol Chem. 2010 Nov;391(11):1249-64. doi: 10.1515/BC.2010.137.
Alcoholic liver disease (ALD) remains a major cause of morbidity and mortality worldwide. For example, the Veterans Administration Cooperative Studies reported that patients with cirrhosis and superimposed alcoholic hepatitis had a 4-year mortality of >60%. The poor prognosis of ALD implies that preventing disease progression would be more effective than treating end-stage liver disease. An obvious avenue of prevention would be to remove the damaging agent; however, the infamously high rate of recidivism in alcoholics makes maintaining abstinence a difficult treatment goal to prevent ALD. Indeed, although the progression of ALD is well-characterized, there is no universally accepted therapy available to halt or reverse this process in humans. With better understanding of the mechanism(s) and risk factors that mediate the initiation and progression of ALD, rational targeted therapy can be developed to treat or prevent ALD. The purpose of this review is to summarize the established and proposed mechanisms by which chronic alcohol abuse damages the liver and to highlight key signaling events known or hypothesized to mediate these effects.
酒精性肝病(ALD)仍然是全球发病率和死亡率的主要原因。例如,退伍军人管理局合作研究报告称,患有肝硬化和叠加性酒精性肝炎的患者 4 年死亡率>60%。ALD 的预后不良意味着预防疾病进展将比治疗终末期肝病更有效。一个明显的预防途径是去除致病因子;然而,酗酒者复发率极高,这使得保持戒酒成为预防 ALD 的一个困难治疗目标。事实上,尽管 ALD 的进展已经得到很好的描述,但目前还没有被广泛接受的疗法可以阻止或逆转人类的这一过程。通过更好地了解介导 ALD 发生和进展的机制和风险因素,可以开发合理的靶向治疗来治疗或预防 ALD。本文综述的目的是总结慢性酒精滥用损害肝脏的既定和提出的机制,并强调已知或假设介导这些效应的关键信号事件。